Hgb Dermalife AB

Active
556971-1632Limited company (AB)Registered 2014HELSINGBORG

Key figures

8 624 781 kr−10,8%
Revenue 2025
−10,8%
Average annual change 2024–2025
02,5 m5 m7,5 m10 m20242025

Key figures

2025

Summary: Hgb Dermalife AB

What kind of company is it?

Hgb Dermalife AB (org. no. 556971-1632) is a limited company (AB). The company was registered in 2014 and has existed for 12 years. Registered seat: Helsingborg. Industry according to Statistics Sweden: specialist medical practice activities, not at hospitals (SNI 86222).

How is the company doing financially?

Net sales in financial year 2025 were 8 624 781 kr, down 10,8 % on the previous year (9 670 322 kr). Net profit for 2025 was 4 271 697 kr (49,5 % of net sales). Employees in financial year 2025: 3. Net sales per employee were 2 874 927 kr. At the end of financial year 2025, total assets were 45 913 375 kr and equity 33 278 200 kr (equity ratio 72,5 %). The annual report for 2025 proposes a dividend of 785 000 kr.

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 2 people. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Dividend

from the annual report
2025

Proposed dividend 785 000 kr.

Summary of annual reports2024–2025
20242025
Sales revenue9 670 3228 624 781
Profit for the reporting year5 508 3184 271 697
Retained earnings of previous periods——
Total assets42 620 65545 913 375
Total liabilities12 844 15112 635 175
Total equity29 776 50433 278 200
Employees33
Proposed dividend—785 000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.